| Reaction Details |
|---|
 | Report a problem with these data |
| Target | Acyl-CoA (8-3)-desaturase |
|---|
| Ligand | BDBM50393166 |
|---|
| Substrate/Competitor | n/a |
|---|
| Meas. Tech. | ChEMBL_852949 (CHEMBL2154133) |
|---|
| IC50 | >100000000±n/a nM |
|---|
| Citation |  Oballa, RM; Belair, L; Black, WC; Bleasby, K; Chan, CC; Desroches, C; Du, X; Gordon, R; Guay, J; Guiral, S; Hafey, MJ; Hamelin, E; Huang, Z; Kennedy, B; Lachance, N; Landry, F; Li, CS; Mancini, J; Normandin, D; Pocai, A; Powell, DA; Ramtohul, YK; Skorey, K; Sørensen, D; Sturkenboom, W; Styhler, A; Waddleton, DM; Wang, H; Wong, S; Xu, L; Zhang, L Development of a liver-targeted stearoyl-CoA desaturase (SCD) inhibitor (MK-8245) to establish a therapeutic window for the treatment of diabetes and dyslipidemia. J Med Chem54:5082-96 (2011) [PubMed] Article |
|---|
| More Info.: | Get all data from this article, Assay Method |
|---|
| |
| Acyl-CoA (8-3)-desaturase |
|---|
| Name: | Acyl-CoA (8-3)-desaturase |
|---|
| Synonyms: | FADS1 | FADS1_HUMAN | FADSD5 | Fatty acid desaturase 1 |
|---|
| Type: | PROTEIN |
|---|
| Mol. Mass.: | 51985.80 |
|---|
| Organism: | Homo sapiens (Human) |
|---|
| Description: | ChEMBL_1513296 |
|---|
| Residue: | 444 |
|---|
| Sequence: | MAPDPVAAETAAQGPTPRYFTWDEVAQRSGCEERWLVIDRKVYNISEFTRRHPGGSRVIS
HYAGQDATDPFVAFHINKGLVKKYMNSLLIGELSPEQPSFEPTKNKELTDEFRELRATVE
RMGLMKANHVFFLLYLLHILLLDGAAWLTLWVFGTSFLPFLLCAVLLSAVQAQAGWLQHD
FGHLSVFSTSKWNHLLHHFVIGHLKGAPASWWNHMHFQHHAKPNCFRKDPDINMHPFFFA
LGKILSVELGKQKKKYMPYNHQHKYFFLIGPPALLPLYFQWYIFYFVIQRKKWVDLAWMI
TFYVRFFLTYVPLLGLKAFLGLFFIVRFLESNWFVWVTQMNHIPMHIDHDRNMDWVSTQL
QATCNVHKSAFNDWFSGHLNFQIEHHLFPTMPRHNYHKVAPLVQSLCAKHGIEYQSKPLL
SAFADIIHSLKESGQLWLDAYLHQ
|
|
|
|---|
| BDBM50393166 |
|---|
| n/a |
|---|
| Name | BDBM50393166 |
|---|
| Synonyms: | CHEMBL2153601 |
|---|
| Type | Small organic molecule |
|---|
| Emp. Form. | C16H15BrFN7O3S |
|---|
| Mol. Mass. | 484.303 |
|---|
| SMILES | OC(=O)Cn1nnc(n1)-c1nnc(s1)N1CCC(CC1)Oc1cc(F)ccc1Br |
|---|
| Structure | 
|
|---|
Search and Browse
